Skip to main content
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
. 2016 Sep;98(7):e143–e146. doi: 10.1308/rcsann.2016.0189

Schwannoma of the biliary tract resembling cholangiocarcinoma: A case report and review

C Marin Campos 1,, I Garcia Sanz 1, JL Muñoz de Nova 1, A Valdés de Anca 1, ME Martín Pérez 1
PMCID: PMC5210012  PMID: 27269434

Abstract

Schwannomas are benign tumours derived from Schwann cells and are extremely rare in the biliary tract. We present the case of a 62-year-old patient with a common bile duct schwannoma that resembled a cholangiocarcinoma. We also review all 17 previously published cases of schwannoma of the biliary tract and discuss the challenges of preoperative diagnosis.

Keywords: Bile ducts, Cholangiocarcinoma, Differential diagnosis, Obstructive jaundice, Schwann cells


Although cholangiocarcinoma is the most common biliary neoplasm causing obstructive jaundice, other malignancies, such as lymphoma or neuroendocrine tumours can be implicated. Currently, only 17 cases of biliary schwannoma, a benign tumour of the bile ducts, have been reported in the literature. We present the case of a patient with a biliary schwannoma that resembled a cholangiocarcinoma and caused jaundice.

Case report

A 62-year-old man presented with obstructive jaundice and abdominal pain. His past medical history included moderate aortic insufficiency, hepatic steatosis and cholecystectomy. Laboratory tests revealed hyperbilirrubinemia (7.56 mg/dL, normal range 0.2–1.3 mg/dL), raised levels of aspartate transaminase 618 U/L (normal range 4–38 U/L), alanine transaminase (924 U/L, normal range 5-41 U/L), gamma-glutamyl transferase (1034 U/L, normal range 7–32 U/L) and alkaline phosphatase (189 U/L, normal range 4–129 U/L), and an international normalised ratio of 1.05 (normal range <1.3).

Abdominal ultrasound showed mild dilation of the intrahepatic biliary tree, with normal extrahepatic biliary ducts. Magnetic resonance cholangiopancreatography (MRCP) revealed both intrahepatic and extrahepatic bile duct dilation secondary to a focal stenosis near the confluence of the right and left hepatic ducts. Subsequent endoscopic retrograde cholangiopancreatography confirmed the stenosis with proximal dilation (Figure 1). Biliary brushings were benign on cytology and a stent was placed. Computed tomography scan revealed no further information as to extent of the disease. Tumour marker levels were 0.68 ng/mL (normal range 0–3 ng/mL) for carcinoembryonic antigen, 1.85 ng/mL (normal range <10 ng/mL) for alpha-fetoprotein and 30.53 U/mL (normal range <30 U/mL) for carbohydrate antigen 19-9.

Figure 1.

Figure 1

Endoscopic retrograde cholangiopancreatography showing a local stenosis at the main bile duct

The patient was discussed at the multidisciplinary team meeting and a presumptive diagnosis of cholangiocarcinoma was reached. Management options were discussed with the patient, and it was decided to proceed to operative intervention.

At the operation, the biliary tree appeared unremarkable, with no palpable mases. The liver was normal and no evidence of metastatic disease was identified (Figure 2). We performed a resection of the common hepatic duct and choledocus, along with a lymphadenectomy of the hepatic pedicle and a Roux-en-Y anastomosis. A frozen section of the surgical specimen margin was intraoperatively diagnosed as biliary intraepithelial neoplasia stage (BilIN) 2–3, so we widened the resection upstream in the biliary tract.

Figure 2.

Figure 2

Exploratory laparotomy

The postoperative course was uneventful and the patient was discharged after 7 days.

Pathology findings revealed a 0.9 cm plexiform schwannoma of the biliary tract, along with reactive inflammatory cell infiltration (Figures 3 and 4). The proximal surgical margin was finally classified as BilIN-2.

Figure 3.

Figure 3

Histological examination showing the biliary tract (*) and the schwannoma (^)

Figure 4.

Figure 4

Histological examination showing a two-component growing pattern

At 18-months follow-up, the patient remained asymptomatic, with no evidence of recurrence.

Discussion

Schwannomas, also kwown as neurilemmomas, are benign tumours that arise from the Schwann cells, the main component of the neural sheath. They typically arise in the soft tissues of the upper limbs, trunk, head, neck, retroperitoneum, mediastinum and pelvis,1,2 but are rarely seen in the digestive tract. Within the gastrointestinal system, most tumours are reported in the stomach, followed by the colorectum and oesophagus. Biliary schwannomas are extremely rare, although the region is densely innervated by both the sympathetic and parasympathetic systems.

Only 17 previous cases have been reported in Medline (Table 1),2,3 with a female predominance (12/17), and an average age of 43 years (range 15–64 years). The most common symptom at presentation was jaundice (13/17), followed by abdominal pain (9/17). Preoperative diagnosis was only suspected in the case published by De Sena et al, as the patient was already known to suffer from type-2 neurofibromatosis, which is associated with schwannomas.2 Unlike cholangiocarcinoma, in which vague abdominal pain is present only in 20% of patients, schwannomas often include this symptom at presentation (9/17), as in our case. This seems rather interesting, even more so when considering that pain in cholangiocarcinoma is associated with advanced stages of disease, whereas it has no relationship with tumour size in schwannomas. Abdominal pain as initial presentation might be explained by the neural origin of schwannomas, although there is no current data to support this.

Table 1.

Published biliary schwannoma case reports

Reference Age M/F Presentation Preoperative diagnosis Tumour location
Whisnant 19746 15 F Abdominal pain + obstructive jaundice + weight loss Distal common bile duct
Balart 19837 56 F Abdominal pain + obstructive jaundice Cholangiocarcinoma vs extrinsic compression Common hepatic duct
Oden 19958 40 F Abdominal pain + obstructive jaundice choledocolithiasis Common bile duct
Jakobs 20039 37 M Abdominal pain + obstructive jaundice Intraductal benign tumour Common hepatic duct
Honjo 200310 48 F Obstructive jaundice Benign non-epithelial tumour Common bile duct
Otani 200511 59 F Abdominal pain Remnant choledochal cyst Intrapancreatic bile duct
Park 200612 53 F Asymptomatic Porta hepatis
Vyas 200613 29 F Abdominal pain + obstructive jaundice Common bile duct
Kamani 200714 39 F Jaundice + weight loss Klatskin tumour Proximal common hepatic duct
Fenoglio 20075 41 F Obstructive jaundice + weight loss Pancreatic tumour Middle common bile duct
Jung 20071 64 F Asymptomatic Proximal common bile duct
Madhusudhan 200915 46 M Obstructive jaundice Cholangiocarcinoma Intrahepatic bile duct
Kulkarni 200916 38 M Abdominal pain + jaundice + weight loss GIST vs lymph nodal mass Porta hepatis
De Sena 200917 58 F Obstructive jaundice in patient with type-2 neurofibromatosis Biliary schwannoma Extrahepatic bile duct
Parameshwarappa 20103 38 M Abdominal pain + obstructive jaundice + weight loss GIST vs lymph nodal mass Common bile duct
Panait 201118 54 F Gastroesophagueal reflux in patient with history of melanoma Metastatic melanoma Porta hepatis
Fonseca 20122 24 M Abdominal pain + obstructive jaundice + weight loss Klatskin tumour Proximal common hepatic duct

Abbreviations: F = female; GIST = gastrointestinal stromal tumor; M = male

Tumour markers are usually normal and imaging tests do not render specific findings either. Although ultrasound appears as the initial procedure in most cases, it does not seem to be helpful for diagnosis. CT generally reveals a homogeneous mass with irregular contrast enhancement. Secondary degenerative changes can sometimes be seen, in what Ackerman and Taylor first called ‘ancient schwannomas’ in 1951.4 These changes occur with tumour growth and include calcification, cystic degradation, bleeding and hyalinisation.1,4 However, schwannomas of the biliary tract have generally been diagnosed at an early stage, and these features will therefore not show up on CT. In our case, only a punctual stenosis was evident on CT, and no signs of macroscopic tumour could be seen.

MRCP findings disclose tumours with low-to-moderate signals in T1-weighed images and heterogeneous high-intensity signals in T2 sequences.5 This heterogeneity can be explained by the two-component growing pattern observed under a microscope. On the one hand, Antoni type A areas are hypercellular zones in which cells sometimes develop a nuclear palisading pattern known as Verocay bodies. In contrast, Antoni type B areas show less cellularity, with cuboid cells that are widely scattered over a myxoid matrix.2

Immunohistochemistry can be useful for the differential diagnosis.2 Being nerve sheath-derived tumours, schwannomas show positivity for neural markers such as vimentin and S-100 protein. They are negative, however, for muscle markers such as actin and desmin, as well as for CD-117 (c-kit) and CD-34 tests, thus differentiating them from gastrointestinal stromal tumors.5

Most schwannomas are diagnosed postoperatively on histological examination, as preoperative diagnosis is almost impossible and these lesions mimic more invasive tumours. As schwannomas are universally benign, long term outcomes are excellent, with no recurrences reported in the literature. Thus, operative resection seems to be curative.

In our case, even if a preoperative diagnosis of a benign biliary lesion had been made, operative resection would still have been advocated, given the progressive nature and location of the patient’s tumour to prevent obstructive liver failure.

Conclusions

Schwannomas are benign lesions that can rarely affect the biliary tree and cause obstructive symptoms. They tend to mimic more worrying tumours and there is a lack of preoperative pathognomonic features, which results in an overtreatment of these lesions. All reported cases within the literature have been published following pathological assessment of the surgical specimen. As schwannomas are universally benign, resection should be considered curative as in this case.

References

  • 1.Jung JH, Joo KR, Chae MJ et al. Extrahepatic biliary schwannomas: a case report. J Korean Med Sci 2007; ; 549–552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Fonseca GM, Montagnini AL, Rocha MS et al. Biliary tract schwannoma: a rare cause of obstructive jaundice in a young patient. World J Gastroenterol 2012; ; 5,305–5,308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Parameshwarappa S, Rodrigues G, Kumar S et al. Schwannoma of common bile duct causing obstructive jaundice. Indian J Surg 2010; ; 333–335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Al Skaini MS, Haroon H, Sardar A et al. Giant retroperitoneal ancient schwannoma: Is preoperative biopsy always mandatory. Int J Surg Case Rep 2015; : 233–236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Fenoglio L, Severini S, Cena P et al. Common bile duct schwannoma: a case report and review of literature. World J Gastroenterol 2007; ; 1,275–1,278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Whisnant JD, Bennett SE, Huffman SR et al. Common bile duct obstruction by granular cell tumor (schwannoma). Am J Dig Dis 1974; ; 471–476. [DOI] [PubMed] [Google Scholar]
  • 7.Balart LA, Hines C, Mitchell W. Granular cell schwannoma of the extrahepatic biliary system. Am J Gastroenterol 1983; ; 297–300. [PubMed] [Google Scholar]
  • 8.Oden B. Neurinoma of the common bile duct; report of a case. Acta Chir Scand 1955; ; 393–397. [PubMed] [Google Scholar]
  • 9.Jakobs R, Albert J, Schilling D et al. Schwannoma of the common bile duct: a rare cause of obstructive jaundice. Endoscopy 2003; ; 695–697. [DOI] [PubMed] [Google Scholar]
  • 10.Honjo Y, Kobayashi Y, Nakamura T et al. Extrahepatic biliary schwannoma. Dig Dis Sci 2003; ; 2,221–2,226. [DOI] [PubMed] [Google Scholar]
  • 11.Otani T, Shioiri T, Mishima H et al. Bile duct schwannoma developed in the remnant choledochal cyst-a case associated with total agenesis of the dorsal pancreas. Dig Liver Dis 2005; ; 705–708. [DOI] [PubMed] [Google Scholar]
  • 12.Park MK, Lee KT, Choi YS et al. [A case of benign schwannoma in the porta hepatis]. Korean J Gastroenterol 2006; ; 164–167. [PubMed] [Google Scholar]
  • 13.Vyas FL, Jesudason MR, Samuel R et al. Schwannoma of bile duct--a case report. Trop Gastroenterol 2006; ; 50–51. [PubMed] [Google Scholar]
  • 14.Kamani F, Dorudinia A, Goravanchi F et al. Extrahepatic bile duct neurilemmoma mimicking Klatskin tumor. Arch Iran Med 2007; ; 264–267. [PubMed] [Google Scholar]
  • 15.Madhusudhan KS, Srivastava DN, Dash NR et al. Case report. Schwannoma of both intrahepatic and extrahepatic bile ducts: a rare case. Br J Radiol 2009; ; e212–5. [DOI] [PubMed] [Google Scholar]
  • 16.Kulkarni N, Andrews SJ, Rao V et al. Case report: Benign porta hepatic schwannoma. Indian J Radiol Imaging 2009; ; 213–215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.De Sena G, Molino C, De Riitis MR et al. [Surgical management of schwannoma of biliary tract]. Chir Ital 2009; ; 119–121. [PubMed] [Google Scholar]
  • 18.Panait L, Learn P, Dimaio C et al. Resection of perihilar biliary schwannoma. Surg Oncol 2011; ; e157–9. [DOI] [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES